The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT-Reference-Cited by-同舟云学术

The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT

Published:2020-09-22 Issue:1 Volume:20 Page:
ISSN:1470-7330
Container-title:Cancer Imaging
language:en
Short-container-title:Cancer Imaging

Author:

Dudoignon David,Pattison David A.,Legallois Damien,Hicks Rodney J.,Aide Nicolas^ORCID

Abstract

Abstract Background Positron Emission Tomography with Computed Tomography (PET/CT) is widely used in the assessment of many diseases, particularly including cancer. However, many factors can affect image quality and diagnostic performance of PET scans using FDG or other PET probes. Main body The aim of this pictorial essay is to review PET/CT protocols that can be useful to overcome these confounding factors in routine clinical situations, with a particular focus on pharmacological interventions and problem-oriented CT acquisition protocols. Conclusion Imaging protocols and representative cases will be discussed, in addition to potential contraindications and precautions to be taken.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1186/s40644-020-00344-9.pdf

Reference38 articles.

1. Hofman MS, Hicks RJ. How we read oncologic FDG PET/CT. Cancer Imaging. 2016;16:35. https://doi.org/10.1186/s40644-016-0091-3.

2. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging. 1999;2:281–7. https://doi.org/10.1016/s1095-0397(99)00029-1.

3. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med. 1993;34:1–6.

4. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med. 1998;39:1030–3.

5. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18f-FDG PET/CT 1.0. Journal of nuclear medicine : official publication. Soc Nucl Med. 2006;47:885–95.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic brain imaging with glucosamine CEST MRI: in vivo characterization and first insights;Scientific Reports;2023-12-12

2. Importance of Blood Glucose Management Before¹⁸F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin;Journal of Nuclear Medicine;2023-07-06

3. The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable;EJNMMI Research;2023-06-20

4. Development and Validation of the Random Forest Model via Combining CT-PET Image Features and Demographic Data for Distant Metastases among Lung Cancer Patients;Journal of Healthcare Engineering;2022-12-13

5. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM);European Journal of Nuclear Medicine and Molecular Imaging;2022-11-05